NEW AGE FOR NUCLEAR MEDICINE
Radioactive drugs are not just diagnosing disease more effectively, they’re now being used for exciting new therapies. They could be revolutionary in fighting cancer in the 21st century, says Sandy McEwan, vice president of radiopharmaceuticals at Ipsen.
Recent News
Hero Awards 2025 – Now Live!
Neuroendocrine Cancer UK Hero Awards 2025 – Launch today!
‘SCAN’ Survey 2025 – One voice matters, thousands create change. Help improve care for NET patients!
Neuroendocrine Cancer UK is pleased to announce the launch of the International Neuroendocrine Cancer Alliance (INCA) ‘Survey of Challenges in Access to Diagnostics and Treatment for Neuroendocrine Cancer Patients’ (SCAN) 2025.
INCA Advocacy with Catherine Bouvier
Cathy facilitated a discussion with members of the INCA community from Australia, Africa, USA, India, UK & Norway to share insights and experiences, but to explore how we can collectively strengthen the voice of patients in shaping their care and the systems that...